4//SEC Filing
van Es Charles 4
Accession 0001886344-25-000005
CIK 0001482981other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:24 PM ET
Size
22.6 KB
Accession
0001886344-25-000005
Insider Transaction Report
Form 4
van Es Charles
Chief Sales Officer
Transactions
- Exercise/Conversion
Common Stock
2025-09-17$10.18/sh+10,000$101,780→ 94,328 total - Sale
Common Stock
2025-09-17$42.04/sh−10,000$420,400→ 84,328 total - Exercise/Conversion
Common Stock
2025-09-17$10.18/sh+10,000$101,780→ 94,328 total - Sale
Common Stock
2025-09-17$42.04/sh−10,000$420,400→ 84,328 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-17−10,000→ 83,750 totalExercise: $10.18Exp: 2030-02-10→ Common Stock (10,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-17−10,000→ 73,750 totalExercise: $10.18Exp: 2030-02-10→ Common Stock (10,000 underlying)
Holdings
- 42,980
Non-Qualified Stock Option (right to buy)
Exercise: $15.36Exp: 2032-08-15→ Common Stock (42,980 underlying) - 27,300
Non-Qualified Stock Option (right to buy)
Exercise: $10.18Exp: 2031-01-11→ Common Stock (27,300 underlying) - 58,043
Non-Qualified Stock Option (right to buy)
Exercise: $15.00Exp: 2031-10-21→ Common Stock (58,043 underlying) - 8,746
Non-Qualified Stock Option (right to buy)
Exercise: $26.18Exp: 2034-03-04→ Common Stock (8,746 underlying) - 14,205
Non-Qualified Stock Option (right to buy)
Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,205 underlying) - 13,218
Non-Qualified Stock Option (right to buy)
Exercise: $33.36Exp: 2035-03-04→ Common Stock (13,218 underlying)
Footnotes (10)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F10]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.18, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The stock option is fully vested and currently exercisable.
- [F5]The stock option is fully vested and currently exercisable.
- [F6]The stock option vests in four equal annual installments beginning on November 27, 2022.
- [F7]The stock option vests in three equal annual installments beginning on August 15, 2025.
- [F8]The stock option vests in four equal annual installments beginning on March 10, 2024.
- [F9]The stock option vests in four equal annual installments beginning on March 4, 2025.
Documents
Issuer
Vita Coco Company, Inc.
CIK 0001482981
Entity typeother
Related Parties
1- filerCIK 0001886344
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 5:24 PM ET
- Size
- 22.6 KB